PARP1 and dry age related macular degeneration: Compounds that inhibit poly (ADP-ribose) polymerase-1 (PARP1) [6] and certain antioxidants such as lutein, zeaxanthin, and resveratrol [7,8,9] have been proposed for treating dry AMD.